BioMarin Pharmaceutical
BMRN
#1392
Rank
A$20.01 B
Marketcap
$105.02
Share price
1.02%
Change (1 day)
-24.99%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): A$0.58 Billion

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are A$2.75 Billion. In 2023 the company made an earning of A$0.30 Billion, an increase over its 2022 earnings that were of A$0.23 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$0.58 B93.01%
2023 A$0.30 B26.07%
2022 A$0.23 B-298.51%
2021 -A$0.13 Billion78.04%
2020 -A$67.69 Million-55.36%
2019 -A$0.16 Billion-33.56%
2018 -A$0.23 Billion297.78%
2017 -A$57.38 Million-95.68%
2016 -A$1.33 Billion437.12%
2015 -A$0.25 Billion23.91%
2014 -A$0.2 Billion-29.25%
2013 -A$0.29 Billion49.23%
2012 -A$0.19 Billion171.11%
2011 -A$69.78 Million103.01%
2010 -A$34.38 Million-3903.54%
2009 A$0.9 M-98.31%
2008 A$53.45 M-189.7%
2007 -A$59.6 Million51.02%
2006 -A$39.47 Million-61.58%
2005 -A$0.11 Billion-56.59%
2004 -A$0.24 Billion95.13%
2003 -A$0.13 Billion12.09%
2002 -A$0.11 Billion73.19%
2001 -A$62.46 Million18.32%
2000 -A$52.79 Million19.65%
1999 -A$44.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.8 Billion-226.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.22 Billion-134.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$46.2 Million-107.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.84 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-A$0.11 Billion-117.46%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.30 B-51.77%๐Ÿ‡บ๐Ÿ‡ธ USA